반응식
[O:1]1[C:5]2([CH2:10][CH2:9][N:8]([C:11]#[N:12])[CH2:7][CH2:6]2)[O:4][CH2:3][CH2:2]1.[OH:13][NH:14][C:15](=N)[CH2:16][CH2:17][CH3:18]>>[CH2:16]([C:15]1[N:12]=[C:11]([N:8]2[CH2:7][CH2:6][C:5]3([O:4][CH2:3][CH2:2][O:1]3)[CH2:10][CH2:9]2)[O:13][N:14]=1)[CH2:17][CH3:18]참가 물질
3
실험 절차
The title compound is prepared from 1,4-dioxa-8-aza-spiro[4.5]decane-8-carbonitrile and N-hydroxy-butyramidine following a procedure analogous to that described in Intermediate 2. LC (method 14): tR=1.16 min; Mass spectrum (ESI+): m/z=254 [M+H]+.
출처 및 근거
- ORD 기록
- ord-32147ce6acdd4ea195cb7a27ac0a68f5
- 출처 데이터셋
- uspto-grants-2014_12
- 특허 번호
- US08921398B2
연결된 노트
불러오는 중…